Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
High-Dose Antithrombin III in Severe Sepsis
2001937 citationsBrian Warren, Alain Eid et al.JAMAprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Pavel Chalupa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavel Chalupa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavel Chalupa more than expected).
This network shows the impact of papers produced by Pavel Chalupa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavel Chalupa. The network helps show where Pavel Chalupa may publish in the future.
Co-authorship network of co-authors of Pavel Chalupa
This figure shows the co-authorship network connecting the top 25 collaborators of Pavel Chalupa.
A scholar is included among the top collaborators of Pavel Chalupa based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Pavel Chalupa. Pavel Chalupa is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Nohýnková, Eva, et al.. (2003). [A case of Babesia microti imported into the Czech Republic from the USA].. PubMed. 142(6). 377–81.11 indexed citations
13.
Chalupa, Pavel, et al.. (2003). Diagnosis of Imported Dengue Fever in the Czech Republic. 27.2 indexed citations
14.
Chalupa, Pavel, et al.. (2001). První výsledky PCR diagnostiky invazivního meningokokového onemocnění.. 7(1).1 indexed citations
15.
Eid, Alain, Peter P. Singer, S. Pillay, et al.. (2001). High-dose a randomized antithrombin III in severe sepsis - A randomized controlled trial.. JAMA. 286(15).2 indexed citations
16.
Warren, Brian, Alain Eid, Pierre Singer, et al.. (2001). High-Dose Antithrombin III in Severe Sepsis. JAMA. 286(15). 1869–1869.937 indexed citations breakdown →
17.
Husa, Petr, et al.. (2001). Efficacy of alpha-interferon therapy of chronic hepatitis patients infected with wild type hepatitis B virus and HBEAG-minus mutant.. PubMed. 45(5-6). 293–7.
Chalupa, Pavel, et al.. (1992). [Viral hepatitis A in the catchment area of the Brno University Hospital 1983-1990].. PubMed. 41(1). 2–7.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.